ARCTICZYMES TECHNOLOGIES ASAARCTICZYMES TECHNOLOGIES ASAARCTICZYMES TECHNOLOGIES ASA

ARCTICZYMES TECHNOLOGIES ASA

No trades
See on Supercharts

AZT fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. It operates through the Enzymes and Corporate segments. The Enzymes segment is composed of sales revenues and operating expenses associated with the subsidiary ArcticZymes AS, which develops and markets recombinant enzymes for use in life science research, molecular diagnostics, and bio-manufacturing. The Corporate segment provides a range of administrative services to the subsidiary. The company was founded by Jan Raa and Gunnar Rorstad in November 1990 and is headquartered in Tromso, Norway.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

AZT does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company